Atlas Trials

Atomoxetine vs Placebo in the Treatment of ADHD in Swedish Children and Adolescents

Clinical trial NCT00191542 · COMPLETED

Trial details

NCT number
NCT00191542
Sponsor
Eli Lilly and Company
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Attention Deficit Hyperactivity Disorder
Start date
2005-03-01
Enrollment
100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.